about
The genome of Nectria haematococca: contribution of supernumerary chromosomes to gene expansionAntifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance PTracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodiesInfections caused by Scedosporium spp.Current knowledge of Trichosporon spp. and TrichosporonosisBlastoschizomyces capitatus infection in patients with leukemia: report of 26 casesInhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistanceSusceptibility of filamentous fungi to voriconazole tested by two microdilution methodsIdentification of Paecilomyces variotii in clinical samples and settingsCell wall integrity signaling in Saccharomyces cerevisiaeEconomic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.The anti-mitochondrial antifungal assay for the discovery and development of new drugs.Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.First reported case of subcutaneous hyalohyphomycosis caused by Paecilomyces variotii.Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens.Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazoleEvaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays.Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature.New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium speciesComparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolatesInfections caused by Fusarium species.New and emerging antifungal agents: impact on respiratory infections.Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safetyIn vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.Disseminated mucormycosis (DM) after pneumonectomy: a case report.Fungal infections: their diagnosis and treatment in transplant recipients.Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.Exophiala oligosperma causing olecranon bursitisClinical pharmacology of antifungal agents in pediatric patients.Fungal spondylodiscitis in a patient recovered from H7N9 virus infection: a case study and a literature review of the differences between Candida and Aspergillus spondylodiscitisSynthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.Pharmacology and clinical use of voriconazole.Classical and alternative components of the mitochondrial respiratory chain in pathogenic fungi as potential therapeutic targets.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Uncommon yeast infections in hematological patients: from diagnosis to treatment.
P2860
Q21563336-7C7C5B41-200C-4AB6-B1D9-49871D4BC30FQ24535844-FF4C8AAF-5681-4D6D-AFB4-D88060454B6EQ24644571-D795ECC4-0F5A-4984-8C3C-9A86E1666B58Q24657691-DFC15771-6217-44AE-8159-0250E44771CFQ26998573-CB28906E-B1C5-4B2F-BB32-946107FF892FQ28239042-F57BE2B3-0B1D-436D-8D8B-BDE8BE7CE6A4Q33255739-A58D4DAB-9A08-4F6C-84FC-9EEAD9EE91C9Q33258644-78748884-13E7-4627-9672-1622A87D2D83Q33592487-3E62CF46-22C1-486A-989D-2B0A9BF310A1Q33592670-991F6976-4CCF-4041-B721-E17B9AC1D5D1Q33939988-BBBAF6DF-7D2D-4162-97BE-F6EA643FFE0CQ34013416-27B291F7-A58A-4835-830A-574FFE445422Q34278041-625B35C7-CCC8-4201-8755-1DC0740BB663Q34306260-155773F6-E5D2-4EBF-8F71-94EECFFB8E29Q34345025-2A01BD24-43CD-4B41-AFF1-D8EBE281B954Q34459120-AEDBED2B-5920-41B0-AD39-CAB53A23C7F2Q34470045-642F0433-057B-4701-A683-B0F425FBDF21Q34509838-B24AE981-EC45-4E96-8FE4-6677C978579EQ34680831-36D2AEB2-500B-4C21-A63F-B529AD1C8DBFQ34851810-340141AD-B791-4FC2-9DB1-EEBEDDFC0DE3Q35002577-8978AC1F-E555-426C-992F-EA47FC652D52Q35139501-55D94CF3-CF14-4BA1-AC9F-1DE90DD56D84Q35140122-47447347-A6CF-43F9-9AF6-FAE539187777Q35622021-5CC1A0B4-EEC5-4CA5-B88E-BF9FA512EBD4Q35627629-AEE020E1-33A5-447E-A9F4-20C0B18F0197Q35825582-CEC9700E-D493-428D-BEAD-CF27D2EE41BEQ36047931-C09D1D7D-9083-48AC-B16E-FBEEE7FBD5DBQ36083775-C00F51E7-CB11-409A-AB97-26C99345B9C2Q36206568-B5CF75FC-5D10-4240-A526-CE01402A6766Q36568458-5D3E688C-7330-4966-99EC-D42019CBA1C5Q36746929-C26019ED-5825-48FF-91FB-9139B2D14431Q36891711-11927000-D70A-4B34-9E5C-2FEBE6F0CCC6Q36968140-373A82D3-2BEA-45BA-8D73-78778968CE8FQ37430792-FC5CF8C3-22DD-4C0D-B29A-EF32A2877D7EQ37499358-EA8117AE-807C-4715-876A-EAA28160B51CQ37568516-BC220D52-629D-4BCD-BFFB-0A6F0599622AQ37641375-E6C3A484-C09E-426B-8ADC-50F12D4981B6Q37832680-63055654-5E35-4CF8-AECD-B337D6C883D5Q37889382-C18CAC6B-F191-43F8-B0F8-7F7D1D8BFD59Q37949642-ACEDBAED-1879-4FA8-8B86-CF0DFF428846
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Uncommon opportunistic fungi: new nosocomial threats.
@ast
Uncommon opportunistic fungi: new nosocomial threats.
@en
Uncommon opportunistic fungi: new nosocomial threats.
@nl
type
label
Uncommon opportunistic fungi: new nosocomial threats.
@ast
Uncommon opportunistic fungi: new nosocomial threats.
@en
Uncommon opportunistic fungi: new nosocomial threats.
@nl
prefLabel
Uncommon opportunistic fungi: new nosocomial threats.
@ast
Uncommon opportunistic fungi: new nosocomial threats.
@en
Uncommon opportunistic fungi: new nosocomial threats.
@nl
P1476
Uncommon opportunistic fungi: new nosocomial threats.
@en
P2093
P356
10.1111/J.1469-0691.2001.TB00005.X
P478
P577
2001-01-01T00:00:00Z